IP-Fälle und Artikel
Variant use, promotional use & partial revocation: easyGroup partially successful at the Court of Appeal
01 September 2025
Two recent Court of Appeal decisions, easyGroup Ltd v Easy Live (Services) Ltd (EasyLive) and easyGroup Ltd v Easyfundraising Ltd…
Sales of own products qualify as genuine use for retail services: Board of Appeal overturns EUIPO’s restrictive approach
01 September 2025
The Board of Appeal has confirmed that retail services limited to the trade mark proprietor’s own products may constitute genuine…
SkyKick in practice: broad specification leads to finding of bad faith
01 September 2025
The United Kingdom Intellectual Property Office (UKIPO) has applied the Supreme Court judgment in SkyKick UK Ltd and Anor v…
Iconix v Dream Pairs: UK Supreme Court confirms relevance of post-sale confusion in infringement assessment
01 September 2025
This Supreme Court decision highlights the relevance of post-sale confusion to the assessment of similarity and confusion in UK trade…
Comparable UK trade marks and genuine use: post-Brexit update
01 September 2025
On 01 January 2021, the United Kingdom Intellectual Property Office (UKIPO) cloned existing EU trade mark registrations and protected EU…
Domain name disputes: decision considers use of a trade mark by a reseller
19 August 2025
The Czech Arbitration Court recently ruled in a Uniform Domain-Name Dispute-Resolution Policy (UDRP) dispute over the domain name lostmarydirect.com.
Patenting in an era of infrastructure renaissance: insights from Europe
12 August 2025
In 2025, Germany amended its constitution to create a staggering €500 billion fund for infrastructure modernisation. This is the largest…
G 1/25 referral: is it necessary to amend the description of the European patent?
07 August 2025
In G 1/25, questions have been referred to the Enlarged Board of Appeal to clarify whether it is necessary to…
Patenting industrial AI in Europe
06 August 2025
While AI assistants, LLMs (large language models) and generative AI are beginning to dramatically change our work and home lives,…
History, opportunities and challenges for protecting gene therapies: perspectives from private practice and industry
01 August 2025
Recent years have seen an explosion of advanced therapies, many of which are based on personalised immune cells, individually edited…
G 1/23 and enablement: are commercially available products state of the art?
01 August 2025
In this eagerly awaited European Patent Office (EPO) decision, the Enlarged Board of Appeal concluded that a product put on…
Seite 1 von 162
Weiter